Showing results (1231-1240 of 1,373) with videos related to

Sort By:
Pageof 138
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2023
circNEIL3 inhibits tumor metastasis through recruiting the E3 ubiquitin ligase Nedd4L to degrade YBX1Shuang Chen, Ke Li, Jiawei Guo, et al.
Journal of Cancer Research and Clinical Oncology|August 28, 2020
Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial resultsSaad Z Usmani, Maria-Victoria Mateos, Vania Hungria, et al.
Oncotarget|May 3, 2017
PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC)Liyan Jiang, Xinying Su, Tianwei Zhang, et al.
Journal of Vascular Surgery|May 1, 1997
Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosisL J Downing, T W Wakefield, R M Strieter, et al.
Blood|October 22, 2010
Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?Hervé Avet-Loiseau, Florent Malard, Loic Campion, et al.
The Review of Scientific Instruments|May 2, 2016
Validation of modelled imaging plates sensitivity to 1-100 keV x-rays and spatial resolution characterisation for diagnostics for the "PETawatt Aquitaine Laser"G Boutoux, D Batani, F Burgy, et al.
Clinical Pharmacokinetics|September 29, 2012
Pharmacokinetic, pharmacodynamic and covariate analysis of subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myelomaPhilippe Moreau, Ievgenii I Karamanesht, Natalia Domnikova, et al.
British Journal of Haematology|May 29, 2024
Twice-weekly induction with ixazomib-lenalidomide-dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant-eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014-03Aurore Perrot, Murielle Roussel, Valerie Lauwers-Cances, et al.
Microbial Biotechnology|June 12, 2024
Coevolutionary analysis of Pseudomonas syringae-phage interactions to help with rational design of phage treatmentsMojgan Rabiey, Emily R Grace, Paulina Pawlos, et al.
Cancers|November 11, 2022
Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer CommitteeAlexandra Masson-Lecomte, Victoire Vaillant, Mathieu Roumiguié, et al.
Pageof 138